Curasen readies Alzheimer's drug CST-3056 for 2024 clinical trial
Clinical Trials Arena - 18-Oct-2023CST-3056 targets cognitive decline in Alzheimer’s with a phase I trial in 2024
Join the club for FREE to access the whole archive and other member benefits.
Healthcare reporter for Clinical Trials Arena
Urtė Fultinavičiūtė is a healthcare journalist based in London, United Kingdom. She currently works as a reporter at Generics Bulletin - Citeline, a Norstella company, covering the off-patent industry and regulatory affairs. Previously, Urtė was a healthcare reporter at Clinical Trials Arena, GlobalData, specializing in clinical data management and clinical strategy.
She holds an MA in International Journalism from City, University of London, with a specialization in Health and Science Journalism, and a first-class honours degree in BA Photojournalism from London Metropolitan University. Her final project, the photo book Comrades, explored the differences between socialism and communism in the UK and Lithuania.
Urtė's articles and photography have been featured in Pink Sheet, In Vivo, Pharmaceutical Technology, Medical Device Network, West End Extra, Islington Tribune, Artscapy, Holloway Express, and JJG Balsas (eng. JJG Voice).
Visit website: https://www.clinicaltrialsarena.com/author/urtefultinaviciute/
See alsoDetails last updated 22-Nov-2024
CST-3056 targets cognitive decline in Alzheimer’s with a phase I trial in 2024